<DOC>
	<DOCNO>NCT01529840</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial evaluate effect somatropin ( Norditropin® ) final height child Noonan syndrome treat 10 year somatropin ( Norditropin® ) attainment optimal final height original trial S/GHD/004/NOO .</brief_summary>
	<brief_title>Somatropin Effect Linear Growth Final Height Subjects With Noonan Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Noonan Syndrome</mesh_term>
	<criteria>Participation original S/GHD/004/NOO trial follow protocol S/GHD/004/NOO without randomise trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>